Cargando…
Statin use is associated with reduced mortality after respiratory viral infection
BACKGROUND: Several studies suggest that statins, besides reducing cardiovascular disease, have anti-inflammatory properties which might provide a benefit in downregulating the immune response after a respiratory viral infection (RVI) and, hence, decreasing subsequent complications. We aim to analys...
Autores principales: | Franco-Peláez, Juan Antonio, Esteban-Lucia, Laura, Zambrano Chacón, María de los Ángeles, Pello-Lázaro, Ana María, Venegas Rodriguez, Ana María, Nieto Roca, Luis, García-Talavera, Camila Sofia, Kallmeyer Mayor, Andrea, Villar Alvarez, Felipe, Fernandez Roblas, Ricardo, Gonzalez-Lorenzo, Oscar, Tuñón, José, Ibañez, Borja, Aceña, Alvaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861028/ https://www.ncbi.nlm.nih.gov/pubmed/33569498 http://dx.doi.org/10.1183/23120541.00365-2020 |
Ejemplares similares
-
Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021) -
Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
por: Devesa, Ana, et al.
Publicado: (2021) -
Prevalence and prognostic value of monoclonal gammopathy in heart failure patients with preserved ejection fraction: A prospective study
por: Devesa, Ana, et al.
Publicado: (2022) -
Anti-Inflammatory Drugs in Patients with Ischemic Heart Disease
por: Pello Lázaro, Ana María, et al.
Publicado: (2021) -
Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomes
por: López‐Castillo, Marta, et al.
Publicado: (2020)